Trivikram Remedies Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 15-11-2024
- Paid Up Capital ₹ 0.10 M
as on 15-11-2024
- Company Age 7 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.95 M
as on 15-11-2024
- Revenue 5.12%
(FY 2023)
- Profit -726.11%
(FY 2023)
- Ebitda -30.82%
(FY 2023)
- Net Worth -36.25%
(FY 2023)
- Total Assets 1.63%
(FY 2023)
About Trivikram Remedies
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.95 M.
Subhash Yadav and Pradeep Mahendru serve as directors at the Company.
- CIN/LLPIN
U74999MH2017PTC291013
- Company No.
291013
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Feb 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Trivikram Remedies Private Limited offer?
Trivikram Remedies Private Limited offers a wide range of products and services, including Bird Food, Poultry & Animal Food, Cattle Feed Additives.
Who are the key members and board of directors at Trivikram Remedies?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Subhash Yadav | Director | 10-Feb-2017 | Current |
Pradeep Mahendru | Director | 10-Aug-2017 | Current |
Financial Performance and Corporate Structure Insights of Trivikram Remedies.
Trivikram Remedies Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 5.12% increase. The company also saw a substantial fall in profitability, with a 726.11% decrease in profit. The company's net worth observed a substantial decline by a decrease of 36.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Trivikram Remedies?
In 2023, Trivikram Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Indian Overseas Bank Creation Date: 30 Jan 2018 | ₹3.95 M | Open |
How Many Employees Work at Trivikram Remedies?
Unlock and access historical data on people associated with Trivikram Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Trivikram Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Trivikram Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.